Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.
Maria ChaparroDiana AcostaCristina RodríguezFrancisco MesoneroMiren VicuñaManuel Barreiro-de AcostaAgnès Fernández-ClotetÁlvaro Hernández MartínezMaite ArroyoIsabel VeraAlexandra Ruiz-CerullaBeatriz SiciliaM José Cabello TapiaCarmen Muñoz VillafrancaJesús Castro-PoceiroJesús Martínez CadillaMónica Sierra-AusínJuan María Vázquez MorónRaquel Vicente LidónFernando BermejoVanesa RoyoMargalida CalafatCarlos González-MuñozaEduardo Leo CarnereroNoemi Manceñido MarcosLeyanira TorrealbaHoracio Alonso-GalánJosé Manuel BenítezYolanda Ber NietoM Teresa Diz-Lois PalomaresMaría José GarcíaJosé Fernando MuñozEdisa María Armesto GonzálezXavier CalvetAlejandro Hernández-CambaRosa Eva Madrigal DomínguezLuis MenchénJosé Lázaro Pérez CalleMarta PiquerasCarmen Dueñas SadornilBelén BotellaTeresa de Jesús Martínez-PérezLaura RamosMaría Carmen Rodríguez-GrauElena San MiguelJosé Luis Fernández ForcelledoPaola María Fradejas SalazarMarifé García-SepulcreAna GutiérrezJordina LlaóEva Sesé AbizandaMaia Boscá-WattsEduardo IyoAlma Keco-HuergaCarmen Martínez BonilElena Peña GonzálezPablo Pérez-GalindoPilar VarelaJavier P Gisbertnull nullPublished in: The American journal of gastroenterology (2023)
Tofacitinib is effective in both short-term and long-term in patients with UC. The safety profile is similar to that previously reported.
Keyphrases